BioCorRX Inc. Discusses FDA Approval Process for Implantable Naltrexone Pellet, BICX104, with The Stock Day Podcast

<div>The Stock Day Podcast welcomed BioCorRx Inc. (OTCQB:BICX)(“the Company”), an addiction treatment solutions company offering a unique approach to the treatment of substance use and other related disorders. Director, CEO, and CFO of the Company, Lourdes Felix, joined Stock Day host Everett Jolly. </div>